Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

類似資料

• The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)
  著者:: Miguel Sampayo-Cordero, 等
  出版事項: (2020-09-01)
• The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)
  著者:: Sampayo-Cordero, Miguel, 等
  出版事項: (2020)
• The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”
  著者:: Sampayo-Cordero, Miguel, 等
  出版事項: (2021)
• Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases
  著者:: Sampayo-Cordero, Miguel, 等
  出版事項: (2019)
• Nobody dares stopping clinical research, not even COVID-19
  著者:: Malfettone, Andrea, 等
  出版事項: (2021)